Watch
KYMR
Kymera Therapeutics, Inc.
Healthcare · Biotechnology · mid-cap ($6.8B)
-20.2%
from rolling 252-day high of $103.00 set 2025-12-08 · 159d ago
Current
$82.21
Decline depth
-20.2%
Decline σ
4.2σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Structural break signals

KYMR qualifies for the Watch on decline depth.

Decline depth
-20.2%
From rolling 252-day high of $103.00, 159d ago. Past the 20% Watch threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.2σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.22% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about KYMR.

KYMR qualifies for the Watch on decline depth — down -20.2% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 4.2σ over 20 bars.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 1 (green).

Earnings on file: 2026-04-30. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $28.06 72.3% of range 52W high $103.00

Sector context · Healthcare

215 other Healthcare tickers are on Broken Stocks.

107 Red List
57 Amber
51 Watch
-34.8% Median decline

Worst in sector: OPRX (-76.6%). Least-bad: BCRX (-20.2%). See all Healthcare listings →

Questions about KYMR

What people ask.

Why is KYMR on Broken Stocks?

KYMR qualifies for the Watch on decline depth. It is down -20.2% from its rolling 252-day high of $103.00, set on 2025-12-08 — 159d ago.

Is KYMR a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. KYMR is down -20.2% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is KYMR a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is KYMR trading inside its 52-week range?

At $82.21, KYMR sits 72.3% of the way from its 52-week low ($28.06) to its 52-week high ($103.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has KYMR been declining?

The current 20.2% decline accrued over 159d, which annualizes to roughly -46.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does KYMR compare to its sector?

There are 215 other Healthcare tickers on Broken Stocks: 107 Red, 57 Amber, 51 Watch, with 24 showing recovering structural signals. Median sector decline is -34.8% — KYMR's decline is shallower than the sector median.

Does KYMR's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-30) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.